Prognostic impact of intra-alveolar tumor spread in pulmonary adenocarcinoma

American Journal of Surgical Pathology

Volumn 39, Issue 6, 2015, Pages 793-801

  Warth, Arne ^a   Muley, Thomas ^b   Kossakowski, Claudia A ^a   Goeppert, Benjamin ^a   Schirmacher, Peter ^a   Dienemann, Hendrik ^a   Weichert, Wilko ^a,c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Thoraxklinik   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

histology; intra alveolar tumor spread; metastasis; prognosis; pulmonary adenocarcinoma; STAS

Indexed keywords

TUMOR MARKERS, BIOLOGICAL;

ADENOCARCINOMA; ADULT; AGED; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PULMONARY ALVEOLI; SURVIVAL ANALYSIS;

ADENOCARCINOMA; ADULT; AGED; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PULMONARY ALVEOLI; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84929907783     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0000000000000409     Document Type: Article

References (23)

1. Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/american thoracic society /european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011;6: 244-285.
2. Travis WD, Brambilla E, Riely GJ. New pathologic classification of lung cancer: Relevance for clinical practice and clinical trials. J Clin Oncol. 2013;31:992-1001.
3. Warth A, Muley T, Meister M, et al. The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival. J Clin Oncol. 2012;30:1438-1446.
4. Wart h A, Penzel R, Lindenmaier H, et al. EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinomas: Patient outcome, interplay with morphology and immunophenotype. Eur Respir J. 2014;43:872-883.
5. Weichert W, Warth A. Early lung cancer with lepidic pattern: Adenocarcinoma in situ, minimally invasive adenocarcinoma, and lepidic predominant adenocarcinoma. Curr Opin Pulm Med. 2014;20:309-316.
6. Kadota K, Yeh YC, Sima CS, et al. The cribriform pattern identifies a subset of acinar predominant tumors with poor prognosis in patients with stage I lung adenocarcinoma: A conceptual proposal to classify cribriform predominant tum ors as a distinct histologic subtype. Mod Pathol. 2014;27:690-700.
7. Moreira AL, Joubert P, Downey RJ, et al. Cribriform and fused glands are patterns of high-grade pulmonary adenocarcinoma. Hum Pathol. 2014;45:213-220.
8. Warth A, Muley T, Kossakowski C, et al. Prognostic impact and clinicopathological correlations of the cribriform pattern in pulmonary adenocarcinoma. J Thorac Oncol. 2015. [Epub ahead of print].
9. Onozato ML, Kovach A E, Yeap BY, et al. Tumor islands in resected early-stage lung adenocarcinomas are associated with unique clinicopathologic and molecular characteristics and worse prognosis. Am J Surg Pathol. 2013;37:287-294.
10. Warth A, Cortis J, Soltermann A, et al. Tumour cell proliferation (Ki-67) in non-small cell lung cancer: A critical reappraisal of its prognostic role. Br J Cancer. 2014;111:1222-1229.
11. Warth A, Muley T, Dienemann H, et al. ROS1 expression and translocations in non-small-cell lung cancer: Clinicopathological analysis of 1478 cases. Histopathology. 2014;65:187-194.
12. Warth A Muley T Herpel E et al. Large-scale comparative analyses of immunomarkers for diagnostic subtyping of non-smallcell lung cancer biopsies. Histopathology. 2012 61 1017-1025.
13. Sarda ri Nia P, Colpaert C, Blyweert B, et al. Prognostic value of nonangiogenic and angiogenic growth patterns in non-small-cell lung cancer. Br J Cancer. 2004;91:1293-1300.
14. Sardari Nia P, Col paert C, Vermeulen P, et al. Different growth patterns of non-small cell lung cancer represent distinct biologic subtypes. Ann Thorac Surg. 2008;85:395-405.
15. Sardari Nia P, Van Marck E, We yler J, et al. Prognostic value of a biologic classification of non-small-cell lung cancer into the growth patterns along with other clinical, pathological and immunohistochemical factors. Eur J Cardiothorac Surg. 2010;38:62 8-636.
16. Amin MB, Tamboli P, Merchant SH, et al. Micropapillary component in lung adenocarcinoma: A distinctive histologic feature with possible prognostic significance. Am J Surg Pathol. 2002;26:358-364.
17. Tsutsumida H, Nomoto M, Goto M, et al. A micropapillary pattern is predictive of a poor prognosis in lung adenocarcinoma, and reduced surfactant apoprotein A expression in the micropapillary pattern is an excellent indicator of a poor prognosis. Mod Pathol. 2007;20:638-647.
18. Onozato ML, Klepeis VE, Yagi Y, et al. A role of three-dimensional (3D)-reconstruction in the classification of lung adenocarcinoma. Anal Cell Pathol. 2012;35:79-84.
19. Kodama K, Ishii G, Miyamoto S, et al. Laminin 5 expression protects against anoikis at aerogenous spread and lepidic growth of human lung ade nocarcinoma. Int J Cancer. 2005;116:876-884.
20. Jin E, Fujiwara M, Nagashima M, et al. Aerogenous spread of primary lung adenocarcinoma induces ultrastructural remodeling of the alveolar capilla ry endothelium. Hum Pathol. 2001;32: 1050-1058.
21. Kuner R, Muley T, Meister M, et al. Glob al gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypes. Lung Cancer. 2009;63:32-38.
22. Wislez M, Antoine M, Rabbe N, et al. Neutrophils pr omote aerogenous spread of lung adenocarcinoma with bronchioloalveolar carcinoma features. Clin Cancer Res. 2007;13:3518-3527.
23. Wu H, Haag D, Muley T, et al. Tumor-microenvironment interaction s studied by zonal transcriptional profiling of squamous cell lung carcinoma. Genes Chromosomes Cancer. 2013;52: 250-264.